论文部分内容阅读
目的:研究新医改下《国家基本药物目录》中基本药物指导价的制定。方法:在总结发现我国药品定价存在的问题和不足的基础上,对新医改下国家基本药物定价提供借鉴,并运用药物经济学原理确定国家基本药物的指导价。结果:运用药物经济学原理,从基本药物的真实成本和治疗效果出发,推导出基本药物的指导价公式。结论:在分析指导价的过程中,尚未考虑到医疗保险和国家补偿机制等因素对价格制定的影响以及患者的接受能力,指导价公式中的一些变量有较强的主观性,会对指导价产生一定的影响。
Objective: To study the formulation of the guide price of essential drugs in “National Essential Drug List” under the new medical reform. Methods: On the basis of summarizing the problems and shortcomings in drug pricing in our country, this paper provides reference for the pricing of national essential drugs under the new medical reform and uses the principle of pharmacoeconomics to determine the guide price of national essential drugs. Results: Based on the principle of pharmacoeconomics, the guide price formula of essential drugs was deduced from the real cost of basic drugs and the therapeutic effect. Conclusion: In the process of analyzing the guide price, some factors such as the medical insurance and the state compensation mechanism have not taken into account the impact on the price formulation and the patients’ acceptability. Some variables in the guide price formula have strong subjectivity, Have a certain impact.